fig1

Chemoprevention of hepatocellular carcinoma associated with metabolic dysfunction-associated steatotic liver disease: an updated review

Figure 1. MASLD-associated HCC. Illustrating the pathogenesis of HCC, first with cardiometabolic risk factors contributing to the formation of steatosis. Then, chronic inflammation and fibrosis ultimately leading to HCC. Created with BioRender.com. TG: Triglycerides; HDL: high-density lipoprotein; BMI: body mass index; MASLD: metabolic dysfunction-associated steatotic liver disease; HCC: hepatocellular carcinoma.

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/